Topic
MedTech
17 published works
Foley & Lardner LLP
What Investors Should Be Asking Before They Fund an AI-Enabled Medtech Company
By Holly Kane
The FDA is giving AI-enabled digital health companies more regulatory clarity, but more clarity does not mean less risk. The agency’s January 2026 Clinical Decision Support Software guidance describes when…
GT Israel Law Blog
From Innovation to IPO: A Strategic Checklist for Medtech Companies
By Michael J. Minahan, David J. Dykeman
After several years of volatility and unfavorable market dynamics, the initial public offering (IPO) market for medical technology companies is beginning to reopen meaningfully. Following the most recent IPO boom…
GT Israel Law Blog
Building a Future-Proof IP Strategy for AI in Medtech
By David J. Dykeman, Andrew (A.J.) Tibbetts, Samuel S. Stone
The healthtech industry is experiencing intense competition as companies race to develop software and artificial intelligence (AI) tools for clinical decision support, medical telemetry, robotic surgery, surgical navigation, medical imaging…
Healthcare Law Insights
Data and Research Rights: Structuring Around Institutional Control
This is the third in a series of articles designed to provide SXSW and LSI USA ’26 attendees and other MedTech professionals with practical considerations for efficiently executing mission-critical life science deals. On March…
The Law and Other Anomalies
2026 Insights on the Medtech/Bio Front
This post, longer than most (apologies), reflects take-aways from a one-hour zoom program reflecting thinking at the annual January San Francisco conference on medtech held under JP Morgan auspices. That…
The Formiti Privacy News Blog
Regulatory Alert: UK MedTech’s Dual Mandate—Navigating the Clash Between
By Formiti
For MedTech manufacturers, the era of siloed compliance is over. Your Quality Assurance (QA) and Data Privacy departments can no longer operate in separate orbits. A unif
Life Sciences Perspectives
A Look Ahead in Life Sciences: What We Are Tracking in the Fourth Quarter of 2024 and Beyond
By Life Sciences Regulatory And Compliance Group
As the life sciences, medtech, and diagnostic industries continue to expand and grow increasingly complex, so does the legal, regulatory, and compliance landscape. To help companies and investors navigate the…
GT TechVenture Views
4 Megatrends Driving the Future of Medtech
By David J. Dykeman, Roman Fayerberg
The medtech industry is positioned for continued growth as the aging world population faces many unmet medical needs. According to market analysts, industry revenue is predicted to grow to nearly $600…
Life Sciences Perspectives
A Look Ahead in Life Sciences: What We Are Tracking in Q1 2024 and Beyond
By Life Sciences Regulatory And Compliance Group
As the life sciences, medtech, and diagnostic industries continue to expand and grow increasingly complex, so does the legal, regulatory, and compliance landscape. To help companies and investors navigate the…
Life Sciences Perspectives
A Look Ahead in Life Sciences: What We Are Tracking in Q4 2023 and Beyond
By Life Sciences Regulatory And Compliance Group
As the life sciences, medtech, and diagnostic industries continue to expand and grow increasingly complex, so do the legal, regulatory, and compliance landscape. To help companies and investors navigate the…